COVID-19 Outbreak-Global Monoclonal Antibodies Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

July 2020 | 116 pages | ID: C107796CB6DCEN
Maia Research

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Monoclonal antibodies are highly uniform antibodies raised by a single B cell clone that target only a particular antigenic epitope.
The Monoclonal Antibodies market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Monoclonal Antibodies industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Monoclonal Antibodies market can be split based on product types, major applications, and important countries as follows:

Key players in the global Monoclonal Antibodies market covered in Chapter 12:
Seattle Genetics, Inc.
Medix Biochemica
Alector
Affimed Therapeutics
MRC Laboratory of Molecular
Aduro Biotech
Alder BioPharmaceuticals
Molecular Partners
Symphogen
AbCellera
ADC Therapeutics S?rl
Biocon
Trianni Inc.
Compass Therapeutics
Sorrento Therapeutics
Kymab
Merus
Esperion Therapeutics Inc.
Orbit Discovery
Agenus Inc.
Allakos
Amgen
Genentech
ABLYNX
NuPathe

In Chapter 4 and 14.1, on the basis of types, the Monoclonal Antibodies market from 2015 to 2025 is primarily split into:
Cancer
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Microbial Diseases
Others

In Chapter 5 and 14.2, on the basis of applications, the Monoclonal Antibodies market from 2015 to 2025 covers:
Subcutaneous
Intravenous

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MONOCLONAL ANTIBODIES INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Overview of Monoclonal Antibodies
1.3 Scope of The Study
  1.3.1 Key Market Segments
  1.3.2 Players Covered
  1.3.3 COVID-19's impact on the Monoclonal Antibodies industry
1.4 Methodology of The Study
1.5 Research Data Source

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Monoclonal Antibodies Market Size, 2015 – 2020
  2.1.2 Global Monoclonal Antibodies Market Size by Type, 2015 – 2020
  2.1.3 Global Monoclonal Antibodies Market Size by Application, 2015 – 2020
  2.1.4 Global Monoclonal Antibodies Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
  2.2.1 Global COVID-19 Status and Economic Overview
  2.2.2 Influence of COVID-19 Outbreak on Monoclonal Antibodies Industry Development

3 INDUSTRY CHAIN ANALYSIS

3.1 Upstream Raw Material Suppliers of Monoclonal Antibodies Analysis
3.2 Major Players of Monoclonal Antibodies
3.3 Monoclonal Antibodies Manufacturing Cost Structure Analysis
  3.3.1 Production Process Analysis
  3.3.2 Manufacturing Cost Structure of Monoclonal Antibodies
  3.3.3 Labor Cost of Monoclonal Antibodies
3.4 Market Distributors of Monoclonal Antibodies
3.5 Major Downstream Buyers of Monoclonal Antibodies Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 GLOBAL MONOCLONAL ANTIBODIES MARKET, BY TYPE

4.1 Global Monoclonal Antibodies Value and Market Share by Type (2015-2020)
4.2 Global Monoclonal Antibodies Production and Market Share by Type (2015-2020)
4.3 Global Monoclonal Antibodies Value and Growth Rate by Type (2015-2020)
  4.3.1 Global Monoclonal Antibodies Value and Growth Rate of Cancer
  4.3.2 Global Monoclonal Antibodies Value and Growth Rate of Autoimmune Diseases
  4.3.3 Global Monoclonal Antibodies Value and Growth Rate of Inflammatory Diseases
  4.3.4 Global Monoclonal Antibodies Value and Growth Rate of Infectious Diseases
  4.3.5 Global Monoclonal Antibodies Value and Growth Rate of Microbial Diseases
  4.3.6 Global Monoclonal Antibodies Value and Growth Rate of Others
4.4 Global Monoclonal Antibodies Price Analysis by Type (2015-2020)

5 MONOCLONAL ANTIBODIES MARKET, BY APPLICATION

5.1 Downstream Market Overview
5.2 Global Monoclonal Antibodies Consumption and Market Share by Application (2015-2020)
5.3 Global Monoclonal Antibodies Consumption and Growth Rate by Application (2015-2020)
  5.3.1 Global Monoclonal Antibodies Consumption and Growth Rate of Subcutaneous (2015-2020)
  5.3.2 Global Monoclonal Antibodies Consumption and Growth Rate of Intravenous (2015-2020)

6 GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY REGIONS

6.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Regions
  6.1.1 Global Monoclonal Antibodies Sales by Regions (2015-2020)
  6.1.2 Global Monoclonal Antibodies Revenue by Regions (2015-2020)
6.2 North America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.3 Europe Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020)
6.6 South America Monoclonal Antibodies Sales and Growth Rate (2015-2020)

7 NORTH AMERICA MONOCLONAL ANTIBODIES MARKET ANALYSIS BY COUNTRIES

7.1 The Influence of COVID-19 on North America Market
7.2 North America Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  7.2.1 North America Monoclonal Antibodies Sales by Countries (2015-2020)
  7.2.2 North America Monoclonal Antibodies Revenue by Countries (2015-2020)
7.3 United States Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.4 Canada Monoclonal Antibodies Sales and Growth Rate (2015-2020)
7.5 Mexico Monoclonal Antibodies Sales and Growth Rate (2015-2020)

8 EUROPE MONOCLONAL ANTIBODIES MARKET ANALYSIS BY COUNTRIES

8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  8.2.1 Europe Monoclonal Antibodies Sales by Countries (2015-2020)
  8.2.2 Europe Monoclonal Antibodies Revenue by Countries (2015-2020)
8.3 Germany Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8.4 UK Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8.5 France Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8.6 Italy Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8.7 Spain Monoclonal Antibodies Sales and Growth Rate (2015-2020)
8.8 Russia Monoclonal Antibodies Sales and Growth Rate (2015-2020)

9 ASIA PACIFIC MONOCLONAL ANTIBODIES MARKET ANALYSIS BY COUNTRIES

9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  9.2.1 Asia Pacific Monoclonal Antibodies Sales by Countries (2015-2020)
  9.2.2 Asia Pacific Monoclonal Antibodies Revenue by Countries (2015-2020)
9.3 China Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.4 Japan Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.5 South Korea Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.6 India Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
9.8 Australia Monoclonal Antibodies Sales and Growth Rate (2015-2020)

10 MIDDLE EAST AND AFRICA MONOCLONAL ANTIBODIES MARKET ANALYSIS BY COUNTRIES

10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  10.2.1 Middle East and Africa Monoclonal Antibodies Sales by Countries (2015-2020)
  10.2.2 Middle East and Africa Monoclonal Antibodies Revenue by Countries (2015-2020)
10.3 Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
10.4 UAE Monoclonal Antibodies Sales and Growth Rate (2015-2020)
10.5 Egypt Monoclonal Antibodies Sales and Growth Rate (2015-2020)
10.6 Nigeria Monoclonal Antibodies Sales and Growth Rate (2015-2020)
10.7 South Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020)

11 SOUTH AMERICA MONOCLONAL ANTIBODIES MARKET ANALYSIS BY COUNTRIES

11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Monoclonal Antibodies Sales, Revenue and Market Share by Countries
  11.2.1 South America Monoclonal Antibodies Sales by Countries (2015-2020)
  11.2.2 South America Monoclonal Antibodies Revenue by Countries (2015-2020)
11.3 Brazil Monoclonal Antibodies Sales and Growth Rate (2015-2020)
11.4 Argentina Monoclonal Antibodies Sales and Growth Rate (2015-2020)
11.5 Columbia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
11.6 Chile Monoclonal Antibodies Sales and Growth Rate (2015-2020)

12 COMPETITIVE LANDSCAPE

12.1 Seattle Genetics, Inc.
  12.1.1 Seattle Genetics, Inc. Basic Information
  12.1.2 Monoclonal Antibodies Product Introduction
  12.1.3 Seattle Genetics, Inc. Production, Value, Price, Gross Margin 2015-2020
12.2 Medix Biochemica
  12.2.1 Medix Biochemica Basic Information
  12.2.2 Monoclonal Antibodies Product Introduction
  12.2.3 Medix Biochemica Production, Value, Price, Gross Margin 2015-2020
12.3 Alector
  12.3.1 Alector Basic Information
  12.3.2 Monoclonal Antibodies Product Introduction
  12.3.3 Alector Production, Value, Price, Gross Margin 2015-2020
12.4 Affimed Therapeutics
  12.4.1 Affimed Therapeutics Basic Information
  12.4.2 Monoclonal Antibodies Product Introduction
  12.4.3 Affimed Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.5 MRC Laboratory of Molecular
  12.5.1 MRC Laboratory of Molecular Basic Information
  12.5.2 Monoclonal Antibodies Product Introduction
  12.5.3 MRC Laboratory of Molecular Production, Value, Price, Gross Margin 2015-2020
12.6 Aduro Biotech
  12.6.1 Aduro Biotech Basic Information
  12.6.2 Monoclonal Antibodies Product Introduction
  12.6.3 Aduro Biotech Production, Value, Price, Gross Margin 2015-2020
12.7 Alder BioPharmaceuticals
  12.7.1 Alder BioPharmaceuticals Basic Information
  12.7.2 Monoclonal Antibodies Product Introduction
  12.7.3 Alder BioPharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.8 Molecular Partners
  12.8.1 Molecular Partners Basic Information
  12.8.2 Monoclonal Antibodies Product Introduction
  12.8.3 Molecular Partners Production, Value, Price, Gross Margin 2015-2020
12.9 Symphogen
  12.9.1 Symphogen Basic Information
  12.9.2 Monoclonal Antibodies Product Introduction
  12.9.3 Symphogen Production, Value, Price, Gross Margin 2015-2020
12.10 AbCellera
  12.10.1 AbCellera Basic Information
  12.10.2 Monoclonal Antibodies Product Introduction
  12.10.3 AbCellera Production, Value, Price, Gross Margin 2015-2020
12.11 ADC Therapeutics S?rl
  12.11.1 ADC Therapeutics S?rl Basic Information
  12.11.2 Monoclonal Antibodies Product Introduction
  12.11.3 ADC Therapeutics S?rl Production, Value, Price, Gross Margin 2015-2020
12.12 Biocon
  12.12.1 Biocon Basic Information
  12.12.2 Monoclonal Antibodies Product Introduction
  12.12.3 Biocon Production, Value, Price, Gross Margin 2015-2020
12.13 Trianni Inc.
  12.13.1 Trianni Inc. Basic Information
  12.13.2 Monoclonal Antibodies Product Introduction
  12.13.3 Trianni Inc. Production, Value, Price, Gross Margin 2015-2020
12.14 Compass Therapeutics
  12.14.1 Compass Therapeutics Basic Information
  12.14.2 Monoclonal Antibodies Product Introduction
  12.14.3 Compass Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.15 Sorrento Therapeutics
  12.15.1 Sorrento Therapeutics Basic Information
  12.15.2 Monoclonal Antibodies Product Introduction
  12.15.3 Sorrento Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.16 Kymab
  12.16.1 Kymab Basic Information
  12.16.2 Monoclonal Antibodies Product Introduction
  12.16.3 Kymab Production, Value, Price, Gross Margin 2015-2020
12.17 Merus
  12.17.1 Merus Basic Information
  12.17.2 Monoclonal Antibodies Product Introduction
  12.17.3 Merus Production, Value, Price, Gross Margin 2015-2020
12.18 Esperion Therapeutics Inc.
  12.18.1 Esperion Therapeutics Inc. Basic Information
  12.18.2 Monoclonal Antibodies Product Introduction
  12.18.3 Esperion Therapeutics Inc. Production, Value, Price, Gross Margin 2015-2020
12.19 Orbit Discovery
  12.19.1 Orbit Discovery Basic Information
  12.19.2 Monoclonal Antibodies Product Introduction
  12.19.3 Orbit Discovery Production, Value, Price, Gross Margin 2015-2020
12.20 Agenus Inc.
  12.20.1 Agenus Inc. Basic Information
  12.20.2 Monoclonal Antibodies Product Introduction
  12.20.3 Agenus Inc. Production, Value, Price, Gross Margin 2015-2020
12.21 Allakos
  12.21.1 Allakos Basic Information
  12.21.2 Monoclonal Antibodies Product Introduction
  12.21.3 Allakos Production, Value, Price, Gross Margin 2015-2020
12.22 Amgen
  12.22.1 Amgen Basic Information
  12.22.2 Monoclonal Antibodies Product Introduction
  12.22.3 Amgen Production, Value, Price, Gross Margin 2015-2020
12.23 Genentech
  12.23.1 Genentech Basic Information
  12.23.2 Monoclonal Antibodies Product Introduction
  12.23.3 Genentech Production, Value, Price, Gross Margin 2015-2020
12.24 ABLYNX
  12.24.1 ABLYNX Basic Information
  12.24.2 Monoclonal Antibodies Product Introduction
  12.24.3 ABLYNX Production, Value, Price, Gross Margin 2015-2020
12.25 NuPathe
  12.25.1 NuPathe Basic Information
  12.25.2 Monoclonal Antibodies Product Introduction
  12.25.3 NuPathe Production, Value, Price, Gross Margin 2015-2020

13 INDUSTRY OUTLOOK

13.1 Market Driver Analysis
  13.1.2 Market Restraints Analysis
  13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 GLOBAL MONOCLONAL ANTIBODIES MARKET FORECAST

14.1 Global Monoclonal Antibodies Market Value & Volume Forecast, by Type (2020-2025)
  14.1.1 Cancer Market Value and Volume Forecast (2020-2025)
  14.1.2 Autoimmune Diseases Market Value and Volume Forecast (2020-2025)
  14.1.3 Inflammatory Diseases Market Value and Volume Forecast (2020-2025)
  14.1.4 Infectious Diseases Market Value and Volume Forecast (2020-2025)
  14.1.5 Microbial Diseases Market Value and Volume Forecast (2020-2025)
  14.1.6 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Monoclonal Antibodies Market Value & Volume Forecast, by Application (2020-2025)
  14.2.1 Subcutaneous Market Value and Volume Forecast (2020-2025)
  14.2.2 Intravenous Market Value and Volume Forecast (2020-2025)
14.3 Monoclonal Antibodies Market Analysis and Forecast by Region
  14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 NEW PROJECT FEASIBILITY ANALYSIS

15.1 Industry Barriers and New Entrants SWOT Analysis
  15.1.1 Porter’s Five Forces Analysis
  15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
LIST OF TABLES AND FIGURES

Figure Product Picture of Monoclonal Antibodies
Table Product Specification of Monoclonal Antibodies
Table Monoclonal Antibodies Key Market Segments
Table Key Players Monoclonal Antibodies Covered
Figure Global Monoclonal Antibodies Market Size, 2015 – 2025
Table Different Types of Monoclonal Antibodies
Figure Global Monoclonal Antibodies Value ($) Segment by Type from 2015-2020
Figure Global Monoclonal Antibodies Market Share by Types in 2019
Table Different Applications of Monoclonal Antibodies
Figure Global Monoclonal Antibodies Value ($) Segment by Applications from 2015-2020
Figure Global Monoclonal Antibodies Market Share by Applications in 2019
Figure Global Monoclonal Antibodies Market Share by Regions in 2019
Figure North America Monoclonal Antibodies Production Value ($) and Growth Rate (2015-2020)
Figure Europe Monoclonal Antibodies Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Monoclonal Antibodies Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Monoclonal Antibodies Production Value ($) and Growth Rate (2015-2020)
Figure South America Monoclonal Antibodies Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Monoclonal Antibodies
Table Upstream Raw Material Suppliers of Monoclonal Antibodies with Contact Information
Table Major Players Headquarters, and Service Area of Monoclonal Antibodies
Figure Major Players Production Value Market Share of Monoclonal Antibodies in 2019
Table Major Players Monoclonal Antibodies Product Types in 2019
Figure Production Process of Monoclonal Antibodies
Figure Manufacturing Cost Structure of Monoclonal Antibodies
Figure Channel Status of Monoclonal Antibodies
Table Major Distributors of Monoclonal Antibodies with Contact Information
Table Major Downstream Buyers of Monoclonal Antibodies with Contact Information
Table Global Monoclonal Antibodies Value ($) by Type (2015-2020)
Table Global Monoclonal Antibodies Value Share by Type (2015-2020)
Figure Global Monoclonal Antibodies Value Share by Type (2015-2020)
Table Global Monoclonal Antibodies Production by Type (2015-2020)
Table Global Monoclonal Antibodies Production Share by Type (2015-2020)
Figure Global Monoclonal Antibodies Production Share by Type (2015-2020)
Figure Global Monoclonal Antibodies Value ($) and Growth Rate of Cancer (2015-2020)
Figure Global Monoclonal Antibodies Value ($) and Growth Rate of Autoimmune Diseases (2015-2020)
Figure Global Monoclonal Antibodies Value ($) and Growth Rate of Inflammatory Diseases (2015-2020)
Figure Global Monoclonal Antibodies Value ($) and Growth Rate of Infectious Diseases (2015-2020)
Figure Global Monoclonal Antibodies Value ($) and Growth Rate of Microbial Diseases (2015-2020)
Figure Global Monoclonal Antibodies Value ($) and Growth Rate of Others (2015-2020)
Figure Global Monoclonal Antibodies Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Monoclonal Antibodies Consumption by Application (2015-2020)
Table Global Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Figure Global Monoclonal Antibodies Consumption Market Share by Application (2015-2020)
Figure Global Monoclonal Antibodies Consumption and Growth Rate of Subcutaneous (2015-2020)
Figure Global Monoclonal Antibodies Consumption and Growth Rate of Intravenous (2015-2020)
Figure Global Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Global Monoclonal Antibodies Revenue (M USD) and Growth (2015-2020)
Table Global Monoclonal Antibodies Sales by Regions (2015-2020)
Table Global Monoclonal Antibodies Sales Market Share by Regions (2015-2020)
Table Global Monoclonal Antibodies Revenue (M USD) by Regions (2015-2020)
Table Global Monoclonal Antibodies Revenue Market Share by Regions (2015-2020)
Table Global Monoclonal Antibodies Revenue Market Share by Regions in 2015
Table Global Monoclonal Antibodies Revenue Market Share by Regions in 2019
Figure North America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Europe Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure South America Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Monoclonal Antibodies Revenue (M USD) and Growth (2015-2020)
Table North America Monoclonal Antibodies Sales by Countries (2015-2020)
Table North America Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table North America Monoclonal Antibodies Revenue (M USD) by Countries (2015-2020)
Table North America Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure United States Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Canada Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Mexico Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Monoclonal Antibodies Revenue (M USD) and Growth (2015-2020)
Table Europe Monoclonal Antibodies Sales by Countries (2015-2020)
Table Europe Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table Europe Monoclonal Antibodies Revenue (M USD) by Countries (2015-2020)
Table Europe Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure Germany Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure UK Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure France Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Italy Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Spain Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Russia Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Monoclonal Antibodies Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Monoclonal Antibodies Sales by Countries (2015-2020)
Table Asia Pacific Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table Asia Pacific Monoclonal Antibodies Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure China Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Japan Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure South Korea Monoclonal Antibodies Sales and Growth (2015-2020)
Figure India Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Southeast Asia Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Australia Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Middle East Monoclonal Antibodies Revenue (M USD) and Growth (2015-2020)
Table Middle East Monoclonal Antibodies Sales by Countries (2015-2020)
Table Middle East and Africa Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Monoclonal Antibodies Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure UAE Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Egypt Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Nigeria Monoclonal Antibodies Sales and Growth (2015-2020)
Figure South Africa Monoclonal Antibodies Sales and Growth (2015-2020)
Figure South America Monoclonal Antibodies Revenue (M USD) and Growth (2015-2020)
Table South America Monoclonal Antibodies Sales by Countries (2015-2020)
Table South America Monoclonal Antibodies Sales Market Share by Countries (2015-2020)
Table South America Monoclonal Antibodies Revenue (M USD) by Countries (2015-2020)
Table South America Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure Brazil Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Argentina Monoclonal Antibodies Sales and Growth Rate (2015-2020)
Figure Columbia Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Chile Monoclonal Antibodies Sales and Growth (2015-2020)
Figure Top 3 Market Share of Monoclonal Antibodies Companies in 2019
Figure Top 6 Market Share of Monoclonal Antibodies Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Seattle Genetics, Inc. Profile
Table Seattle Genetics, Inc. Product Introduction
Figure Seattle Genetics, Inc. Production and Growth Rate
Figure Seattle Genetics, Inc. Value ($) Market Share 2015-2020
Table Medix Biochemica Profile
Table Medix Biochemica Product Introduction
Figure Medix Biochemica Production and Growth Rate
Figure Medix Biochemica Value ($) Market Share 2015-2020
Table Alector Profile
Table Alector Product Introduction
Figure Alector Production and Growth Rate
Figure Alector Value ($) Market Share 2015-2020
Table Affimed Therapeutics Profile
Table Affimed Therapeutics Product Introduction
Figure Affimed Therapeutics Production and Growth Rate
Figure Affimed Therapeutics Value ($) Market Share 2015-2020
Table MRC Laboratory of Molecular Profile
Table MRC Laboratory of Molecular Product Introduction
Figure MRC Laboratory of Molecular Production and Growth Rate
Figure MRC Laboratory of Molecular Value ($) Market Share 2015-2020
Table Aduro Biotech Profile
Table Aduro Biotech Product Introduction
Figure Aduro Biotech Production and Growth Rate
Figure Aduro Biotech Value ($) Market Share 2015-2020
Table Alder BioPharmaceuticals Profile
Table Alder BioPharmaceuticals Product Introduction
Figure Alder BioPharmaceuticals Production and Growth Rate
Figure Alder BioPharmaceuticals Value ($) Market Share 2015-2020
Table Molecular Partners Profile
Table Molecular Partners Product Introduction
Figure Molecular Partners Production and Growth Rate
Figure Molecular Partners Value ($) Market Share 2015-2020
Table Symphogen Profile
Table Symphogen Product Introduction
Figure Symphogen Production and Growth Rate
Figure Symphogen Value ($) Market Share 2015-2020
Table AbCellera Profile
Table AbCellera Product Introduction
Figure AbCellera Production and Growth Rate
Figure AbCellera Value ($) Market Share 2015-2020
Table ADC Therapeutics S?rl Profile
Table ADC Therapeutics S?rl Product Introduction
Figure ADC Therapeutics S?rl Production and Growth Rate
Figure ADC Therapeutics S?rl Value ($) Market Share 2015-2020
Table Biocon Profile
Table Biocon Product Introduction
Figure Biocon Production and Growth Rate
Figure Biocon Value ($) Market Share 2015-2020
Table Trianni Inc. Profile
Table Trianni Inc. Product Introduction
Figure Trianni Inc. Production and Growth Rate
Figure Trianni Inc. Value ($) Market Share 2015-2020
Table Compass Therapeutics Profile
Table Compass Therapeutics Product Introduction
Figure Compass Therapeutics Production and Growth Rate
Figure Compass Therapeutics Value ($) Market Share 2015-2020
Table Sorrento Therapeutics Profile
Table Sorrento Therapeutics Product Introduction
Figure Sorrento Therapeutics Production and Growth Rate
Figure Sorrento Therapeutics Value ($) Market Share 2015-2020
Table Kymab Profile
Table Kymab Product Introduction
Figure Kymab Production and Growth Rate
Figure Kymab Value ($) Market Share 2015-2020
Table Merus Profile
Table Merus Product Introduction
Figure Merus Production and Growth Rate
Figure Merus Value ($) Market Share 2015-2020
Table Esperion Therapeutics Inc. Profile
Table Esperion Therapeutics Inc. Product Introduction
Figure Esperion Therapeutics Inc. Production and Growth Rate
Figure Esperion Therapeutics Inc. Value ($) Market Share 2015-2020
Table Orbit Discovery Profile
Table Orbit Discovery Product Introduction
Figure Orbit Discovery Production and Growth Rate
Figure Orbit Discovery Value ($) Market Share 2015-2020
Table Agenus Inc. Profile
Table Agenus Inc. Product Introduction
Figure Agenus Inc. Production and Growth Rate
Figure Agenus Inc. Value ($) Market Share 2015-2020
Table Allakos Profile
Table Allakos Product Introduction
Figure Allakos Production and Growth Rate
Figure Allakos Value ($) Market Share 2015-2020
Table Amgen Profile
Table Amgen Product Introduction
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2015-2020
Table Genentech Profile
Table Genentech Product Introduction
Figure Genentech Production and Growth Rate
Figure Genentech Value ($) Market Share 2015-2020
Table ABLYNX Profile
Table ABLYNX Product Introduction
Figure ABLYNX Production and Growth Rate
Figure ABLYNX Value ($) Market Share 2015-2020
Table NuPathe Profile
Table NuPathe Product Introduction
Figure NuPathe Production and Growth Rate
Figure NuPathe Value ($) Market Share 2015-2020
Table Market Driving Factors of Monoclonal Antibodies
Table Merger, Acquisition and New Investment
Table Global Monoclonal Antibodies Market Value ($) Forecast, by Type
Table Global Monoclonal Antibodies Market Volume Forecast, by Type
Figure Global Monoclonal Antibodies Market Value ($) and Growth Rate Forecast of Cancer (2020-2025)
Figure Global Monoclonal Antibodies Market Volume ($) and Growth Rate Forecast of Cancer (2020-2025)
Figure Global Monoclonal Antibodies Market Value ($) and Growth Rate Forecast of Autoimmune Diseases (2020-2025)
Figure Global Monoclonal Antibodies Market Volume ($) and Growth Rate Forecast of Autoimmune Diseases (2020-2025)
Figure Global Monoclonal Antibodies Market Value ($) and Growth Rate Forecast of Inflammatory Diseases (2020-2025)
Figure Global Monoclonal Antibodies Market Volume ($) and Growth Rate Forecast of Inflammatory Diseases (2020-2025)
Figure Global Monoclonal Antibodies Market Value ($) and Growth Rate Forecast of Infectious Diseases (2020-2025)
Figure Global Monoclonal Antibodies Market Volume ($) and Growth Rate Forecast of Infectious Diseases (2020-2025)
Figure Global Monoclonal Antibodies Market Value ($) and Growth Rate Forecast of Microbial Diseases (2020-2025)
Figure Global Monoclonal Antibodies Market Volume ($) and Growth Rate Forecast of Microbial Diseases (2020-2025)
Figure Global Monoclonal Antibodies Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Monoclonal Antibodies Market Volume ($) and Growth Rate Forecast of Others (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Subcutaneous (2020-2025)
Figure Market Volume and Growth Rate Forecast of Subcutaneous (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Intravenous (2020-2025)
Figure Market Volume and Growth Rate Forecast of Intravenous (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery


More Publications